Neurobiological mechanisms of electroconvulsive therapy for depression: Insights into hippocampal volumetric increases from clinical and preclinical studies
- PMID: 38238933
- DOI: 10.1111/jnc.16054
Neurobiological mechanisms of electroconvulsive therapy for depression: Insights into hippocampal volumetric increases from clinical and preclinical studies
Abstract
Depression is a highly prevalent and disabling psychiatric disorder. The hippocampus, which plays a central role in mood regulation and memory, has received considerable attention in depression research. Electroconvulsive therapy (ECT) is the most effective treatment for severe pharmacotherapy-resistant depression. Although the working mechanism of ECT remains unclear, recent magnetic resonance imaging (MRI) studies have consistently reported increased hippocampal volumes following ECT. The clinical implications of these volumetric increases and the specific cellular and molecular significance are not yet fully understood. This narrative review brings together evidence from animal models and human studies to provide a detailed examination of hippocampal volumetric increases following ECT. In particular, our preclinical MRI research using a mouse model is consistent with human findings, demonstrating a marked increase in hippocampal volume following ECT. Notable changes were observed in the ventral hippocampal CA1 region, including dendritic growth and increased synaptic density at excitatory synapses. Interestingly, inhibition of neurogenesis did not affect the ECT-related hippocampal volumetric increases detected on MRI. However, it remains unclear whether these histological and volumetric changes would be correlated with the clinical effect of ECT. Hence, future research on the relationships between cellular changes, ECT-related brain volumetric changes, and antidepressant effect could benefit from a bidirectional translational approach that integrates human and animal models. Such translational research may provide important insights into the mechanisms and potential biomarkers associated with ECT-induced hippocampal volumetric changes, thereby advancing our understanding of ECT for the treatment of depression.
Keywords: ECT; MRI; VBM; depression; hippocampus; neurogenesis.
© 2024 The Authors. Journal of Neurochemistry published by John Wiley & Sons Ltd on behalf of International Society for Neurochemistry.
References
REFERENCES
-
- Abe, Y., Komaki, Y., Seki, F., Shibata, S., Okano, H., & Tanaka, K. F. (2019). Correlative study using structural MRI and super‐resolution microscopy to detect structural alterations induced by long‐term optogenetic stimulation of striatal medium spiny neurons. Neurochemistry International, 125, 163–174.
-
- Abe, Y., Yagishita, S., Sano, H., Sugiura, Y., Dantsuji, M., Suzuki, T., Mochizuki, A., Yoshimaru, D., Hata, J., Matsumoto, M., Taira, S., Takeuchi, H., Okano, H., Ohno, N., Suematsu, M., Inoue, T., Nambu, A., Watanabe, M., & Tanaka, K. F. (2023). Shared GABA transmission pathology in dopamine agonist‐ and antagonist‐induced dyskinesia. Cell Reports Medicine, 4, 101208.
-
- Abe, Y., Yokoyama, K., Kato, T., Yagishita, S., Tanaka, K. F., & Takamiya, A. (2024). Neurogenesis‐independent mechanisms of MRI‐detectable hippocampal volume increase following electroconvulsive stimulation. Neuropsychopharmacology. https://doi.org/10.1038/s41386‐023‐01791‐1
-
- Anderson, B. J. (2011). Plasticity of gray matter volume: The cellular and synaptic plasticity that underlies volumetric change. Developmental Psychobiology, 53, 456–465.
-
- Arancibia‐Carcamo, I. L., Ford, M. C., Cossell, L., Ishida, K., Tohyama, K., & Attwell, D. (2017). Node of Ranvier length as a potential regulator of myelinated axon conduction speed. eLife, 6, e23329.
Publication types
MeSH terms
Grants and funding
- JP21K20911/A Grant-in-Aid from the Japan Society for the Promotion of Science (JSPS) KAKENHI
- JP22K15215/A Grant-in-Aid from the Japan Society for the Promotion of Science (JSPS) KAKENHI
- JP22K15756/A Grant-in-Aid from the Japan Society for the Promotion of Science (JSPS) KAKENHI
- JP19dm0207069/Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) by the Japan Agency for Medical Research and Development (AMED)
LinkOut - more resources
Full Text Sources
Miscellaneous
